|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/08 | |
| C07K 7/06 | |||
| A61P 3/14 | |||
| A61P 5/20 | |||
| A61P 5/00 |
| (11) | Number of the document | 3539555 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19159337.5 |
| Date of filing the European patent application | 2010-07-29 | |
| (97) | Date of publication of the European application | 2019-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 22969509 P | 2009-07-29 | US | |
| 25581609 P | 2009-10-28 | US | |
| 31363510 P | 2010-03-12 | US |
| (72) |
KARIM, Felix, US
BARUCH, Amos, US
MACLEAN, Derek, US
DAS, Kanad, US
YIN, Qun, US
|
| (73) |
Kai Pharmaceuticals, Inc.,
270 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (54) | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS |
| THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS |